Virus News and Research

Latest Virus News and Research

The ability of natural flavonoids to inhibit SARS-CoV-2

A recent systematic review discusses naturally occurring flavonoids as a promising antiviral alternative against SARS-CoV-2.

31 Oct 2021

U of U Health scientists lead new studies investigating the long-term effects of COVID-19

University of Utah Health scientists are on the leading edge of a pair of large studies investigating the long-term effects of COVID-19.

30 Oct 2021

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

University of Utah Health scientists are leading an effort to determine if salivary glands infected with the virus that causes COVID-19 could diminish a person’s long-term immunity to the disease after being immunized or after recovering from the illness.

30 Oct 2021

Needle-free COVID-19 vaccine could soon be possible

A needle-free COVID-19 vaccination could be possible, with University of Queensland scientists successfully protecting mice from the virus by administering a US-developed vaccine candidate with a 'patch'.

30 Oct 2021

Honeybees increase social distancing in response to a common parasite

Honeybees increase social distancing when their hive is under threat from a parasite, finds a new study led by an international team involving researchers at UCL and the University of Sassari, Italy.

30 Oct 2021

Therapeutic heparin for preventing COVID-19 deaths is four times higher than the prophylactic dose

The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according to a study reported on October 14 in the British Medical Journal.

30 Oct 2021

Researchers discover potential new Covid-19 treatment

Researchers have identified a potential new treatment that suppresses the replication of SARS-CoV-2, the coronavirus that causes Covid-19.

30 Oct 2021

Prompt procurement and rapid pace of vaccination likely to have a greater impact than vaccine efficacy

For low- and middle-income countries, a COVID-19 vaccination program built on prompt procurement, effective on-the-ground distribution, and a rapid pace of vaccination (the total number of doses given daily) is likely to have a greater public health impact than one focused on relatively small differences in vaccine efficacy, according to a study led by researchers at Massachusetts General Hospital.

30 Oct 2021

Researchers appeal for thoughtful regulation of infectious disease research

COVID-19 has killed close to 5 million people worldwide, and the crisis has given rise to uncertainties about both the origins of the virus and how to respond to future pandemics.

30 Oct 2021

Consortium of Louisiana's research institutions to investigate the mysteries of "long COVID"

A consortium of Louisiana's leading biomedical research institutions, headed by the Pennington Biomedical Research Center, partnered with LSU and Tulane Health Science Centers in New Orleans, will investigate the mysteries of "long COVID" under a National Institutes of Health award.

29 Oct 2021

Study: mRNA vaccines associated with more immunity than prior COVID-19 infection

A nationwide study from the Centers for Disease Control and Prevention shows that mRNA COVID-19 vaccines are associated with significantly more immunity than a prior COVID-19 infection.

29 Oct 2021

New evidence that SARS-CoV-2 virus can infect the inner ear

Many Covid-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting that the SARS-CoV-2 virus may be able to infect the inner ear.

29 Oct 2021

Researchers develop eToeholds for safe, effective RNA and cellular therapies

RNAs are best known as the molecules that translate information encoded in genes into proteins with their myriad of activities.

29 Oct 2021

UKHSA’s Green Book updated to allow flexibility in COVID-19 booster vaccines for vulnerable people

COVID-19 booster vaccines can now be given sooner than six months after their second dose to certain vulnerable people where this makes operational sense, as the UKHSA's Green Book has been updated.

29 Oct 2021

More than seven million of UK's most vulnerable people receive COVID-19 booster jabs

Over seven million of the UK's most vulnerable people have now received their COVID-19 booster jab, the latest figures show today (Friday 29 October 2021).

29 Oct 2021

Study focuses on the high hepatitis C rates in pregnant people

Hepatitis C virus (HCV) infection can lead to long-term health problems including liver damage, liver failure, cirrhosis, liver cancer and even death. These outcomes are especially dangerous for pregnant people and their babies.

29 Oct 2021

NIH study identifies distinct mechanisms of long-term HIV control in two people after treatment disruption

Research led by scientists at the National Institutes of Health has identified two distinct ways that people with HIV can control the virus for an extended period after stopping antiretroviral therapy (ART) under medical supervision.

29 Oct 2021

UK Government opens a new COVID testing center in Renfrew

The test center, located at Renfrew High Street Car Park (PA4 8QL), is part of the largest network of diagnostic testing facilities created in British history.

29 Oct 2021

Perceived invincibility as an individual-level factor capable of threatening COVID-19 suppression

Researchers from the University of Nevada have investigated the factors that can drive vaccine hesitancy and reluctance to obey anti-covid measures.

29 Oct 2021

Study finds immunity against SARS-CoV-2 delta variant waned after BNT162b2 vaccine second dose

Researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors.

29 Oct 2021

Virus News and Research

Latest Virus News and Research

The ability of natural flavonoids to inhibit SARS-CoV-2

U of U Health scientists lead new studies investigating the long-term effects of COVID-19

Researchers explore whether salivary glands infected with SARS-CoV-2 can diminish long-term immunity

Needle-free COVID-19 vaccine could soon be possible

Honeybees increase social distancing in response to a common parasite

Therapeutic heparin for preventing COVID-19 deaths is four times higher than the prophylactic dose

Researchers discover potential new Covid-19 treatment

Prompt procurement and rapid pace of vaccination likely to have a greater impact than vaccine efficacy

Researchers appeal for thoughtful regulation of infectious disease research

Consortium of Louisiana's research institutions to investigate the mysteries of "long COVID"

Study: mRNA vaccines associated with more immunity than prior COVID-19 infection

New evidence that SARS-CoV-2 virus can infect the inner ear

Researchers develop eToeholds for safe, effective RNA and cellular therapies

UKHSA’s Green Book updated to allow flexibility in COVID-19 booster vaccines for vulnerable people

More than seven million of UK's most vulnerable people receive COVID-19 booster jabs

Study focuses on the high hepatitis C rates in pregnant people

NIH study identifies distinct mechanisms of long-term HIV control in two people after treatment disruption

UK Government opens a new COVID testing center in Renfrew

Perceived invincibility as an individual-level factor capable of threatening COVID-19 suppression

Study finds immunity against SARS-CoV-2 delta variant waned after BNT162b2 vaccine second dose

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in